May 08, 2025

FDA Warns Physicians of Tianeptine Dangers

The FDA warns physicians about unapproved tianeptine products that are linked to severe adverse events, including dependence, toxicity, and death.

Conexiant

May 08, 2025

Naltrexone Forms Show Similar AUD Results

A randomized trial of 248 hospitalized patients with alcohol use disorder found no significant difference in drinking reduction between oral and injectable naltrexone.

Conexiant

May 08, 2025

Mindfulness Therapy May Reduce Opioid Craving Signals

Mindfulness training helped normalize brain responses to positive emotion in people with opioid use disorder, reducing their craving and improving emotional regulation.

Conexiant

May 07, 2025

Foot Device Beats PT for Back Pain

A personalized foot-worn device reduced pain by 56% in individuals with chronic low back pain compared to traditional physical therapy.

Conexiant

May 05, 2025

Men With Panic Disorder Use More Substances, Study 

Researchers analyzed over 10,000 adults and found that individuals with panic disorder reported more severe alcohol and tobacco use, especially among men, with no significant differences across racial groups.

Conexiant

May 01, 2025

Psilocybin Shows Promise for Parkinson's Disease

First clinical trial demonstrates psilocybin therapy significantly improves depression, anxiety, and motor symptoms.

Conexiant

April 30, 2025

Sitting Raises Neck Pain Risk by Over 80%

"Targeted preventative measures, particularly for high-risk groups like [women] and employees, are necessary."

Conexiant

April 29, 2025

Obesity Independently Hinders Remission in RA

Study shows BMI above 30 correlates with poorer treatment outcomes regardless of comorbidities

Conexiant

April 29, 2025

Nerve Blocks Compared for Knee Replacement

"The ACB group seemed to have some advantages in the rapid postoperative quadriceps muscle strength recovery."

Conexiant